In conclusion, patients with acromegaly have a high prevalence of dyslipidemia, driven by excess GH, insulin resistance, and alterations in lipid metabolism, which collectively increase the risk of atherosclerotic cardiovascular disease. Here, GH1 is linked to Insulin resistance.